Advances in Exosomes and Cancer Biomarkers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 12 September 2025 | Viewed by 165
Special Issue Editor
2. Division of Biochemistry, Department of Basic Science, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA
Interests: radiation; general surgery; cancers; exosomes; cancer biomarkers; liquid biopsy; tumor microenvironment; molecular diagnosis
Special Issue Information
Dear Colleagues,
Exosomes have emerged as key players in cancer biology, acting as carriers of molecular information between tumor cells and their microenvironment. In recent years, significant progress has been made in understanding the role of exosomes in cancer, particularly as potential biomarkers for diagnoses, prognoses, and treatment monitoring. These nanosized extracellular vesicles are capable of transporting proteins, lipids, and nucleic acids, reflecting the molecular landscape of their cell of origin. This has opened new avenues for the development of non-invasive diagnostic tools, especially in the context of liquid biopsies. Despite these advances, challenges remain in standardizing the isolation and analysis of exosomes, and further research is needed to validate their utility as reliable cancer biomarkers across different malignancies. This Special Issue is intended to reflect the recent developments and the ongoing challenges in leveraging exosomes as biomarkers to improve cancer outcomes.
Dr. Nathan Wall
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- exosomes
- cancer biomarkers
- liquid biopsy
- tumor microenvironment
- molecular diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
